1
|
Lichtenauer M, Goebel B, Fritzenwanger M, Förster M, Betge S, Lauten A, Figulla HR, Jung C. Simulated temporary hypoxia triggers the release of CD31+/Annexin+ endothelial microparticles: A prospective pilot study in humans. Clin Hemorheol Microcirc 2015; 61:83-90. [DOI: 10.3233/ch-141908] [Citation(s) in RCA: 34] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
Affiliation(s)
- Michael Lichtenauer
- Clinic of Internal Medicine II, Department of Cardiology, Paracelsus Medical University of Salzburg, Austria
| | - Bjoern Goebel
- Universitätsherzzentrum Thüringen, Clinic of Internal Medicine I, Department of Cardiology, Friedrich Schiller University Jena, Germany
| | - Michael Fritzenwanger
- Universitätsherzzentrum Thüringen, Clinic of Internal Medicine I, Department of Cardiology, Friedrich Schiller University Jena, Germany
| | - Martin Förster
- Universitätsherzzentrum Thüringen, Clinic of Internal Medicine I, Department of Cardiology, Friedrich Schiller University Jena, Germany
| | - Stefan Betge
- Universitätsherzzentrum Thüringen, Clinic of Internal Medicine I, Department of Cardiology, Friedrich Schiller University Jena, Germany
| | - Alexander Lauten
- Universitätsherzzentrum Thüringen, Clinic of Internal Medicine I, Department of Cardiology, Friedrich Schiller University Jena, Germany
| | - Hans-Reiner Figulla
- Universitätsherzzentrum Thüringen, Clinic of Internal Medicine I, Department of Cardiology, Friedrich Schiller University Jena, Germany
| | - Christian Jung
- Universitätsherzzentrum Thüringen, Clinic of Internal Medicine I, Department of Cardiology, Friedrich Schiller University Jena, Germany
| |
Collapse
|
2
|
Li RWS, Yang C, Sit ASM, Kwan YW, Lee SMY, Hoi MPM, Chan SW, Hausman M, Vanhoutte PM, Leung GPH. Uptake and protective effects of ergothioneine in human endothelial cells. J Pharmacol Exp Ther 2014; 350:691-700. [PMID: 25022513 DOI: 10.1124/jpet.114.214049] [Citation(s) in RCA: 40] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/11/2023] Open
Abstract
Ergothioneine is a thiourea derivative of histidine found in food, especially mushrooms. Experiments in cell-free systems and chemical assays identified this compound as a powerful antioxidant. Experiments were designed to test the ability of endothelial cells to take up ergothioneine and hence benefit from protection against oxidative stress. Reverse-transcription polymerase chain reaction and Western blotting demonstrated transcription and translation of an ergothioneine transporter in human brain microvascular endothelial cells (HBMECs). Uptake of [(3)H]ergothioneine occurred by the organic cation transporter novel type-1 (OCTN-1), was sodium-dependent, and was reduced when expression of OCTN-1 was silenced by small interfering RNA (siRNA). The effect of ergothioneine on the production of reactive oxygen species (ROS) in HBMECs was measured using dichlorodihydrofluorescein and lucigenin, and the effect on cell viability was studied using the MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay. ROS production and cell death induced by pyrogallol, xanthine oxidase plus xanthine, and high glucose were suppressed by ergothioneine. The antioxidant and cytoprotective effects of ergothioneine were abolished when OCTN-1 was silenced using siRNA. The expression of NADPH oxidase 1 was decreased, and those of glutathione reductase, catalase, and superoxide dismutase enhanced by the compound. In isolated rat basilar arteries, ergothioneine attenuated the reduction in acetylcholine-induced relaxation caused by pyrogallol, xanthine oxidase plus xanthine, or incubation in high glucose. Chronic treatment with the compound improved the response to acetylcholine in arteries of rats with streptozotocin-induced diabetes. In summary, ergothioneine is taken up by endothelial cells via OCTN-1, where the compound then protects against oxidative stress, curtailing endothelial dysfunction.
Collapse
Affiliation(s)
- Rachel W S Li
- State Key Laboratory for Pharmaceutical Biotechnologies and Department of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong (R.W.S.L., A.S.M.S., P.M.V., G.P.H.L.); Ethnic Drug Screening and Pharmacology Center, Key Laboratory of Chemistry in Ethnic Medicinal Resources, State Ethnic Affairs Commission and Ministry of Education, Yunnan Minzu University, Kunming, China (C.Y.); School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong (Y.W.K.); Institute of Chinese Medical Sciences, University of Macau, Macao, China (S.M.Y.L., M.P.M.H.); State Key Laboratory of Chinese Medicine and Molecular Pharmacology, Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hong Kong (S.W.C.); and Entia Biosciences Inc., Sherwood, Oregon (M.H.)
| | - C Yang
- State Key Laboratory for Pharmaceutical Biotechnologies and Department of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong (R.W.S.L., A.S.M.S., P.M.V., G.P.H.L.); Ethnic Drug Screening and Pharmacology Center, Key Laboratory of Chemistry in Ethnic Medicinal Resources, State Ethnic Affairs Commission and Ministry of Education, Yunnan Minzu University, Kunming, China (C.Y.); School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong (Y.W.K.); Institute of Chinese Medical Sciences, University of Macau, Macao, China (S.M.Y.L., M.P.M.H.); State Key Laboratory of Chinese Medicine and Molecular Pharmacology, Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hong Kong (S.W.C.); and Entia Biosciences Inc., Sherwood, Oregon (M.H.)
| | - Albert S M Sit
- State Key Laboratory for Pharmaceutical Biotechnologies and Department of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong (R.W.S.L., A.S.M.S., P.M.V., G.P.H.L.); Ethnic Drug Screening and Pharmacology Center, Key Laboratory of Chemistry in Ethnic Medicinal Resources, State Ethnic Affairs Commission and Ministry of Education, Yunnan Minzu University, Kunming, China (C.Y.); School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong (Y.W.K.); Institute of Chinese Medical Sciences, University of Macau, Macao, China (S.M.Y.L., M.P.M.H.); State Key Laboratory of Chinese Medicine and Molecular Pharmacology, Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hong Kong (S.W.C.); and Entia Biosciences Inc., Sherwood, Oregon (M.H.)
| | - Y W Kwan
- State Key Laboratory for Pharmaceutical Biotechnologies and Department of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong (R.W.S.L., A.S.M.S., P.M.V., G.P.H.L.); Ethnic Drug Screening and Pharmacology Center, Key Laboratory of Chemistry in Ethnic Medicinal Resources, State Ethnic Affairs Commission and Ministry of Education, Yunnan Minzu University, Kunming, China (C.Y.); School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong (Y.W.K.); Institute of Chinese Medical Sciences, University of Macau, Macao, China (S.M.Y.L., M.P.M.H.); State Key Laboratory of Chinese Medicine and Molecular Pharmacology, Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hong Kong (S.W.C.); and Entia Biosciences Inc., Sherwood, Oregon (M.H.)
| | - Simon M Y Lee
- State Key Laboratory for Pharmaceutical Biotechnologies and Department of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong (R.W.S.L., A.S.M.S., P.M.V., G.P.H.L.); Ethnic Drug Screening and Pharmacology Center, Key Laboratory of Chemistry in Ethnic Medicinal Resources, State Ethnic Affairs Commission and Ministry of Education, Yunnan Minzu University, Kunming, China (C.Y.); School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong (Y.W.K.); Institute of Chinese Medical Sciences, University of Macau, Macao, China (S.M.Y.L., M.P.M.H.); State Key Laboratory of Chinese Medicine and Molecular Pharmacology, Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hong Kong (S.W.C.); and Entia Biosciences Inc., Sherwood, Oregon (M.H.)
| | - Maggie P M Hoi
- State Key Laboratory for Pharmaceutical Biotechnologies and Department of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong (R.W.S.L., A.S.M.S., P.M.V., G.P.H.L.); Ethnic Drug Screening and Pharmacology Center, Key Laboratory of Chemistry in Ethnic Medicinal Resources, State Ethnic Affairs Commission and Ministry of Education, Yunnan Minzu University, Kunming, China (C.Y.); School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong (Y.W.K.); Institute of Chinese Medical Sciences, University of Macau, Macao, China (S.M.Y.L., M.P.M.H.); State Key Laboratory of Chinese Medicine and Molecular Pharmacology, Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hong Kong (S.W.C.); and Entia Biosciences Inc., Sherwood, Oregon (M.H.)
| | - S W Chan
- State Key Laboratory for Pharmaceutical Biotechnologies and Department of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong (R.W.S.L., A.S.M.S., P.M.V., G.P.H.L.); Ethnic Drug Screening and Pharmacology Center, Key Laboratory of Chemistry in Ethnic Medicinal Resources, State Ethnic Affairs Commission and Ministry of Education, Yunnan Minzu University, Kunming, China (C.Y.); School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong (Y.W.K.); Institute of Chinese Medical Sciences, University of Macau, Macao, China (S.M.Y.L., M.P.M.H.); State Key Laboratory of Chinese Medicine and Molecular Pharmacology, Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hong Kong (S.W.C.); and Entia Biosciences Inc., Sherwood, Oregon (M.H.)
| | - Marvin Hausman
- State Key Laboratory for Pharmaceutical Biotechnologies and Department of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong (R.W.S.L., A.S.M.S., P.M.V., G.P.H.L.); Ethnic Drug Screening and Pharmacology Center, Key Laboratory of Chemistry in Ethnic Medicinal Resources, State Ethnic Affairs Commission and Ministry of Education, Yunnan Minzu University, Kunming, China (C.Y.); School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong (Y.W.K.); Institute of Chinese Medical Sciences, University of Macau, Macao, China (S.M.Y.L., M.P.M.H.); State Key Laboratory of Chinese Medicine and Molecular Pharmacology, Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hong Kong (S.W.C.); and Entia Biosciences Inc., Sherwood, Oregon (M.H.)
| | - Paul M Vanhoutte
- State Key Laboratory for Pharmaceutical Biotechnologies and Department of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong (R.W.S.L., A.S.M.S., P.M.V., G.P.H.L.); Ethnic Drug Screening and Pharmacology Center, Key Laboratory of Chemistry in Ethnic Medicinal Resources, State Ethnic Affairs Commission and Ministry of Education, Yunnan Minzu University, Kunming, China (C.Y.); School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong (Y.W.K.); Institute of Chinese Medical Sciences, University of Macau, Macao, China (S.M.Y.L., M.P.M.H.); State Key Laboratory of Chinese Medicine and Molecular Pharmacology, Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hong Kong (S.W.C.); and Entia Biosciences Inc., Sherwood, Oregon (M.H.)
| | - George P H Leung
- State Key Laboratory for Pharmaceutical Biotechnologies and Department of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong (R.W.S.L., A.S.M.S., P.M.V., G.P.H.L.); Ethnic Drug Screening and Pharmacology Center, Key Laboratory of Chemistry in Ethnic Medicinal Resources, State Ethnic Affairs Commission and Ministry of Education, Yunnan Minzu University, Kunming, China (C.Y.); School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong (Y.W.K.); Institute of Chinese Medical Sciences, University of Macau, Macao, China (S.M.Y.L., M.P.M.H.); State Key Laboratory of Chinese Medicine and Molecular Pharmacology, Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hong Kong (S.W.C.); and Entia Biosciences Inc., Sherwood, Oregon (M.H.)
| |
Collapse
|
5
|
Buday A, Orsy P, Godó M, Mózes M, Kökény G, Lacza Z, Koller A, Ungvári Z, Gross ML, Benyó Z, Hamar P. Elevated systemic TGF-beta impairs aortic vasomotor function through activation of NADPH oxidase-driven superoxide production and leads to hypertension, myocardial remodeling, and increased plaque formation in apoE(-/-) mice. Am J Physiol Heart Circ Physiol 2010; 299:H386-95. [PMID: 20511416 DOI: 10.1152/ajpheart.01042.2009] [Citation(s) in RCA: 47] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
Abstract
The role of circulating, systemic TGF-beta levels in endothelial function is not clear. TGF-beta(1) may cause endothelial dysfunction in apolipoprotein E-deficient (apoE(-/-)) mice via stimulation of reactive oxygen species (ROS) production by the NADPH oxidase (NOX) system and aggravate aortic and heart remodeling and hypertension. Thoracic aorta (TA) were isolated from 4-mo-old control (C57Bl/6), apoE(-/-), TGF-beta(1)-overexpressing (TGFbeta(1)), and crossbred apoE(-/-) x TGFbeta(1) mice. Endothelium-dependent relaxation was measured before and after incubation with apocynin (NOX inhibitor) or superoxide dismutase (SOD; ROS scavenger). Superoxide production within the vessel wall was determined by dihydroethidine staining under confocal microscope. In 8-mo-old mice, aortic and myocardial morphometric changes, plaque formation by en face fat staining, and blood pressure were determined. Serum TGF-beta(1) levels (ELISA) were elevated in TGFbeta(1) mice without downregulation of TGF-beta-I receptor (immunohistochemistry). In the aortic wall, superoxide production was enhanced and NO-dependent relaxation diminished in apoE(-/-) x TGFbeta(1) mice but improved significantly after apocynin or SOD. Myocardial capillary density was reduced, fibrocyte density increased, aortic wall was thicker, combined lesion area was greater, and blood pressure was higher in the apoE(-/-) x TGFbeta vs. C57Bl/6 mice. Our results demonstrate that elevated circulating TGF-beta(1) causes endothelial dysfunction through NOX activation-induced oxidative stress, accelerating atherosclerosis and hypertension in apoE(-/-) mice. These findings may provide a mechanism explaining accelerated atherosclerosis in patients with elevated plasma TGFbeta(1).
Collapse
Affiliation(s)
- Anna Buday
- Institute of Pathophysiology, Dept. of Medicine, Semmelweis Univ., Budapest, 1089 Nagyvárad tér 4, Hungary
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|